As of 2025-07-01, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 33.64 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-06-27 | -68.76 |
| 2025-06-25 | -74.97 |
| 2025-06-23 | -76.71 |
| 2025-06-20 | -78.67 |
| 2025-06-18 | -79.16 |
| 2025-06-10 | -79.37 |
| 2025-06-06 | -78.22 |
| 2025-06-05 | -77.26 |
| 2025-06-03 | -78.43 |
| 2025-06-02 | -79.78 |
| 2025-05-30 | -72.05 |
| 2025-05-28 | -77.75 |
| 2025-05-27 | -80.25 |
| 2025-05-23 | -81.31 |
| 2025-05-22 | -84.99 |
| 2025-05-20 | -90.89 |
| 2025-05-15 | -92.45 |
| 2025-05-13 | -93.43 |
| 2025-05-12 | -95.00 |
| 2025-05-09 | -92.47 |
| 2025-05-08 | -90.30 |
| 2025-05-07 | -85.64 |
| 2025-05-06 | -83.80 |
| 2025-05-05 | -89.93 |
| 2025-05-02 | -89.91 |
| 2025-05-01 | -86.07 |
| 2025-04-30 | -85.72 |
| 2025-04-29 | -89.24 |
| 2025-04-28 | -92.08 |
| 2025-04-25 | -92.69 |
| 2025-04-23 | -97.05 |
| 2025-04-22 | -93.82 |
| 2025-04-21 | -93.61 |
| 2025-04-16 | -90.85 |
| 2025-04-15 | -92.00 |
| 2025-04-14 | -90.79 |
| 2025-04-11 | -82.17 |
| 2025-04-09 | -87.01 |
| 2025-04-08 | -81.49 |
| 2025-04-07 | -85.85 |
| 2025-04-04 | -93.74 |
| 2025-04-03 | -95.33 |
| 2025-04-02 | -103.98 |
| 2025-04-01 | -106.65 |
| 2025-03-31 | -106.63 |